Hims & Hers Health Inc
NYSE:HIMS

Watchlist Manager
Hims & Hers Health Inc Logo
Hims & Hers Health Inc
NYSE:HIMS
Watchlist
Price: 40.02 USD 7.96%
Market Cap: 9.1B USD

Hims & Hers Health Inc
Cash Interest Paid

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Hims & Hers Health Inc
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Hims & Hers Health Inc
NYSE:HIMS
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Cash Interest Paid
$262m
CAGR 3-Years
18%
CAGR 5-Years
8%
CAGR 10-Years
-2%
CVS Health Corp
NYSE:CVS
Cash Interest Paid
-$3B
CAGR 3-Years
-10%
CAGR 5-Years
-2%
CAGR 10-Years
-17%
Cigna Corp
NYSE:CI
Cash Interest Paid
$1.3B
CAGR 3-Years
3%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Cash Interest Paid
$247.2m
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
0%
Guardant Health Inc
NASDAQ:GH
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hims & Hers Health Inc
Glance View

Once upon a time in the bustling landscape of telehealth services, Hims & Hers Health Inc. emerged as a pioneering force, reshaping the narrative around personal wellness and healthcare accessibility. Founded with a direct-to-consumer approach, the company cleverly positioned itself at the intersection of convenience and necessity. Operating primarily through an online platform, Hims & Hers offers a range of health-related products and services targeting conditions often stigmatized or considered sensitive, such as hair loss, erectile dysfunction, skincare, mental health, and more. The company’s business model hinges on its ability to bypass traditional healthcare barriers, providing easy access to licensed healthcare professionals and personalized treatment plans through a seamless internet-based interface. Their revenue model is multifaceted, but at its core are product sales and subscription services. Customers begin their journey by completing a brief online consultation, which, in many states, can involve a healthcare professional reviewing their information without an in-person visit. Once approved, the company's network of telehealth providers prescribes medications, which are conveniently delivered to customers’ doorsteps. Whether purchasing single products or opting for monthly subscriptions, users are drawn to the discretion and accessibility of the service. Hims & Hers markets its offerings directly through savvy digital campaigns, leveraging the power of modern e-commerce to reach younger demographics who appreciate privacy and efficiency in managing their health. Thus, the company stands as a compelling example of how technology can democratize healthcare, wrapped seamlessly within the bounds of consumer-friendly digital infrastructure.

HIMS Intrinsic Value
24.47 USD
Overvaluation 39%
Intrinsic Value
Price

See Also

Back to Top